Publications by authors named "James Ms Wason"

Claim this Profile
E
Evaluating the metabolic effects of neoadjuvant treatment in clear cell renal cell carcinoma using hyperpolarized [1- C]pyruvate MRI.
Ines Horvat-Menih, Mary A McLean, Jonathan Birchall, Maria Jesus Zamora Morales, Marta Wylot, James Ms Wason

Abdom Radiol (NY)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control, Fludrocortisone or Midodrine for the treatment of Orthostatic Hypotension: CONFORM-OH pilot RCT and economic evaluation.
Helen Mossop, Sarah Al Ashmori, Tumi Sotire, Emma Clark, Gillian Watson, James Ms Wason

Health Technol Assess· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritis.
Leher Gumber, Fiona Rayner, Theophile Bigirumurame, Bernard Dyke, Andrew Melville, James Ms Wason

RMD Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building ADMISSION - A research collaborative to transform understanding of multiple long-term conditions for people admitted to hospital.
Miles D Witham, Victoria Bartle, Sue Bellass, Jonathan G Bunn, Duncan Cartner, James Ms Wason

J Multimorb Comorb· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A hybrid approach to sample size re-estimation in cluster randomized trials with continuous outcomes.
Samuel K Sarkodie, James Ms Wason, Michael J Grayling

Stat Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracorporeal photopheresis (ECP) in the treatment of chronic lung allograft dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK).
Andrew J Fisher, Michael White, Nicola Goudie, Anneka Kershaw, Julia Phillipson, James Ms Wason

BMJ Open Respir Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Operational complexities in international clinical trials: a systematic review of challenges and proposed solutions.
Leher Gumber, Opeyemi Agbeleye, Alex Inskip, Ross Fairbairn, Madeleine Still, James Ms Wason

BMJ Open· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine.
Nicola J Wyatt, Hannah Watson, Carl A Anderson, Nicholas A Kennedy, Tim Raine, James Ms Wason

BMJ Open· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A hybrid approach to comparing parallel-group and stepped-wedge cluster-randomized trials with a continuous primary outcome when there is uncertainty in the intra-cluster correlation.
Samuel K Sarkodie, James Ms Wason, Michael J Grayling

Clin Trials· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point estimation following a two-stage group sequential trial.
Michael J Grayling, James Ms Wason

Stat Methods Med Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Employing a latent variable framework to improve efficiency in composite endpoint analysis.
Martina McMenamin, Jessica K Barrett, Anna Berglind, James Ms Wason

Stat Methods Med Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A latent variable model for improving inference in trials assessing the effect of dose on toxicity and composite efficacy endpoints.
James Ms Wason, Shaun R Seaman

Stat Methods Med Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A web application for the design of multi-arm clinical trials.
Michael J Grayling, James Ms Wason

BMC Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Group sequential designs for stepped-wedge cluster randomised trials.
Michael J Grayling, James Ms Wason, Adrian P Mander

Clin Trials· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-stage phase II oncology designs using short-term endpoints for early stopping.
Cornelia U Kunz, James Ms Wason, Meinhard Kieser

Stat Methods Med Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of an embedded, micro-randomised trial to investigate non-compliance in telehealth interventions.
Lisa M Law, Nuwani Edirisinghe, James Ms Wason

Clin Trials· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of statistical designs for improving the efficiency of phase II studies in oncology.
James Ms Wason, Thomas Jaki

Stat Methods Med Res· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis